[{"Assets_0_Q3_USD":33734000000.0,"EarningsPerShareBasic_1_Q3_USD":1.16,"EarningsPerShareBasic_3_Q3_USD":2.3,"EarningsPerShareDiluted_1_Q3_USD":1.16,"EarningsPerShareDiluted_3_Q3_USD":2.3,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":3511000000.0,"NetIncomeLoss_1_Q3_USD":1901000000.0,"NetIncomeLoss_3_Q3_USD":3760000000.0,"StockholdersEquity_0_Q3_USD":13640000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":1636000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":1637000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":1632000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":1633000000.0,"Ticker":"BMY","CIK":"14272","name":"BRISTOL MYERS SQUIBB CO","OfficialName":"Bristol-Myers Squibb Company Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"162365472986.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20181025"}]